Publicacións en colaboración con investigadores/as de Universidade de Vigo (12)

2024

  1. Sex differences in delay times in ST-segment elevation myocardial infarction: A cohort study

    Medicina Clinica, Vol. 163, Núm. 3, pp. 115-120

  2. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225

2023

  1. Automatic Assessment of Transcatheter Aortic Valve Implantation Results on Four-Dimensional Computed Tomography Images Using Artificial Intelligence

    Bioengineering, Vol. 10, Núm. 10

  2. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

2022

  1. An study on the influence of collagen fiber directions in TAVs performance using FEM

    Journal of the Mechanical Behavior of Biomedical Materials, Vol. 126

  2. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  3. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  4. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol

    PLoS ONE, Vol. 16, Núm. 7 July

  2. Predicting TAVI paravalvular regurgitation outcomes based on numerical simulation of the aortic annulus eccentricity and perivalvular areas

    Computer Methods in Biomechanics and Biomedical Engineering, Vol. 24, Núm. 14, pp. 1629-1637

2020

  1. Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial

    Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 536-545

  2. Ramipril in High-Risk Patients With COVID-19

    Journal of the American College of Cardiology, Vol. 76, Núm. 3, pp. 268-276